Johnny Gutierrez

1.3k total citations
20 papers, 937 citations indexed

About

Johnny Gutierrez is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Johnny Gutierrez has authored 20 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Johnny Gutierrez's work include Antimicrobial Resistance in Staphylococcus (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Johnny Gutierrez is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Johnny Gutierrez collaborates with scholars based in United States, Germany and United Kingdom. Johnny Gutierrez's co-authors include Y. Gloria Meng, Chingwei V. Lee, Hans‐Peter Gerber, Germaine Fuh, Franklin Peale, Xiumin Wu, Napoleone Ferrara, Wei‐Ching Liang, Ajay K. Malik and Ling Fu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Johnny Gutierrez

20 papers receiving 873 citations

Peers

Johnny Gutierrez
Aaron C. Spalding United States
Agda Karina Eterovic United States
Tammey Naab United States
Thomas Hager Germany
Matthew J. Oberley United States
Johnny Gutierrez
Citations per year, relative to Johnny Gutierrez Johnny Gutierrez (= 1×) peers Claudia Meier

Countries citing papers authored by Johnny Gutierrez

Since Specialization
Citations

This map shows the geographic impact of Johnny Gutierrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnny Gutierrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnny Gutierrez more than expected).

Fields of papers citing papers by Johnny Gutierrez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnny Gutierrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnny Gutierrez. The network helps show where Johnny Gutierrez may publish in the future.

Co-authorship network of co-authors of Johnny Gutierrez

This figure shows the co-authorship network connecting the top 25 collaborators of Johnny Gutierrez. A scholar is included among the top collaborators of Johnny Gutierrez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnny Gutierrez. Johnny Gutierrez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gutierrez, Johnny, Carolin Kurz, Rose Edmonds, et al.. (2024). Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer’s Disease Patients. Journal of Alzheimer s Disease. 101(2). 563–576. 1 indexed citations
2.
Lee, Julie, Balázs István Tóth, Stephen Schauer, et al.. (2024). CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti‐tau antibody semorinemab. Alzheimer s & Dementia. 20(11). 7940–7953. 6 indexed citations
3.
Dash, Ajit, Jill Fredrickson, Nicholas Lewin‐Koh, et al.. (2022). Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial. Hepatology. 78(3). 847–862. 24 indexed citations
4.
Tom, Irene, Victoria C. Pham, Kenneth J. Katschke, et al.. (2020). Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy. Proceedings of the National Academy of Sciences. 117(18). 9952–9963. 40 indexed citations
5.
Takahashi, Chikara, et al.. (2020). Evaluation of oligonucleotide conjugated antibodies as reporter molecules in single-cell assays. The Journal of Immunology. 204(1_Supplement). 86.35–86.35. 1 indexed citations
6.
Baruch, Amos, Leslie W. Chinn, Anjali Vaze, et al.. (2020). Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans. Proceedings of the National Academy of Sciences. 117(46). 28992–29000. 76 indexed citations
8.
Gutierrez, Johnny, Stacey A. Maskarinec, Yi Cao, et al.. (2019). Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia. Open Forum Infectious Diseases. 6(4). ofz126–ofz126. 12 indexed citations
9.
Gutierrez, Johnny, Nicholas Lewin‐Koh, Aklile Berhanu, et al.. (2019). Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Staphylococcus aureus Bacteremia. Open Forum Infectious Diseases. 6(4). ofz090–ofz090. 11 indexed citations
10.
Cao, Yi, Kyu Hong, Oleg Mayba, et al.. (2018). A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection. Clinical Infectious Diseases. 68(9). 1502–1511. 41 indexed citations
11.
Zhou, Xiaoju, Sophie M. Lehar, Johnny Gutierrez, et al.. (2016). Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice. mAbs. 8(8). 1612–1619. 62 indexed citations
12.
Gutierrez, Johnny, et al.. (2014). Understanding heterogeneity in the host response to Staphylococcus aureus infection for prognostic biomarker discovery. Critical Care. 18(S2). 2 indexed citations
13.
Gutierrez, Johnny, et al.. (2013). Linfoma no-Hodgkin primario de bazo y su manejo laparoscópico. 14(4). 196. 1 indexed citations
14.
Lin, Kui, James R. Taylor, Thomas D. Wu, et al.. (2011). TMEFF2 Is a PDGF-AA Binding Protein with Methylation-Associated Gene Silencing in Multiple Cancer Types Including Glioma. PLoS ONE. 6(4). e18608–e18608. 38 indexed citations
15.
Gutierrez, Johnny, Gottfried E. Konecny, Kyu Hong, et al.. (2008). A New ELISA for Use in a 3-ELISA System to Assess Concentrations of VEGF Splice Variants and VEGF110 in Ovarian Cancer Tumors. Clinical Chemistry. 54(3). 597–601. 7 indexed citations
16.
Sharp, Helen M., et al.. (2008). Caregiver and Patient Reported Outcomes after Repair of Cleft Lip and/or Palate in the Philippines. The Cleft Palate-Craniofacial Journal. 45(2). 163–171. 17 indexed citations
17.
Gerber, Hans‐Peter, Xiumin Wu, Lanlan Yu, et al.. (2007). Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies. Proceedings of the National Academy of Sciences. 104(9). 3478–3483. 77 indexed citations
18.
Liang, Wei‐Ching, Xiumin Wu, Franklin Peale, et al.. (2005). Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF. Journal of Biological Chemistry. 281(2). 951–961. 282 indexed citations
19.
Konecny, Gottfried E., Y. Gloria Meng, Michael Untch, et al.. (2004). Association between HER-2/ neu and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients. Clinical Cancer Research. 10(5). 1706–1716. 230 indexed citations
20.
Ramírez-Ronda, C H, et al.. (1982). Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: A prospective randomized trial. Journal of Antimicrobial Chemotherapy. 9(suppl A). 125–129. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026